Search Results - "Allahyari, Abolghasem"

Topical Silymarin Administration for Prevention of Capecitabine‐Induced Hand–Foot Syndrome: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial by Elyasi, Sepideh, Shojaee, Farzaneh Sadat Rezazadeh, Allahyari, Abolghasem, Karimi, Gholamreza

“…Hand–foot syndrome (HFS) is a frequent dose‐limiting adverse reaction of capecitabine in patient with gastrointestinal cancers. Silymarin is a polyphenolic…”
Get full text

Clinical features and disease severity in an Iranian population of inpatients with COVID-19 by Nabavi, Shima, Javidarabshahi, Zahra, Allahyari, Abolghasem, Ramezani, Mohammad, Seddigh-Shamsi, Mohsen, Ravanshad, Sahar, AkbariRad, Mina, Ebrahimzadeh, Farnoosh, Khatami, Shohre, Emadzadeh, Maryam, Saeedian, Neda, Zarifian, Ahmadreza, Miri, Maryam, Rezaeetalab, Fariba, Hejazi, Sepide, Basiri, Reza, Mozdourian, Mahnaz

“…Coronavirus disease 2019 (COVID-19) can present with a variety of symptoms. Severity of the disease may be associated with several factors. Here, we review…”
Get full text

Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature by Allahyari, Abolghasem, Maharati, Amirhosein, Jafari-Nozad, Amir Masoud, Zangooie, Alireza

“…Synchronous or metachronous multiple primary malignancies (MPMs) are a known phenomenon. These occurrences may be spontaneous or related to environmental risk…”
Get full text

Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial by Bondad, Nazanin, Boostani, Reza, Barri, Alireza, Elyasi, Sepideh, Allahyari, Abolghasem

“…Purpose Neuropathy is one of the most prevalent and dose-limiting side effects of platinum chemotherapeutic agents. N-acetylcysteine is an antioxidant thiol…”
Get full text

Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran by Goshayeshi, Ladan, Akbari Rad, Mina, Bergquist, Robert, Allahyari, Abolghasem, Hashemzadeh, Kamila, Milani, Nasrin, Gholian-Aval, Mahdi, Rezaeitalab, Fariba, Sadeghi Quchani, Mohammad Jafar, Nahbandani, Zahra, Khodashahi, Mandana, Javid, Zahra, Mozdourian, Mahnaz, Yaghoubi, Mohammad Ali, Mozaheb, Zahra, Seddigh-Shamsi, Mohsen, Moeini Nodeh, Mohammad, Nabavi, Shima, Mosannen Mozaffari, Hooman, Farzanehfar, Mohammadreza, Lotfi, Zahra, Shariati, Alireza, Bonakdaran, Shekoofe, Rezaieyazdi, Zahra, Mirfeizi, Zahra, Miri, Maryam, Bassiri, Reza, Ataei Azimi, Sajjad

“…Abstract Background Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to…”
Get full text

The effects of low‐dose anthracycline‐based chemotherapy on the levels of serum NT‐proBNP level and left ventricular systolic and diastolic dysfunctions: A prospective observational study by Mohammadi, Fatemeh, Bigdelu, Leila, Allahyari, Abolghasem, Morovatdar, Negar, Rahimi, Vafa Baradaran

“…Background and Aims The present study aimed to evaluate the relationship between serum N‐terminal (NT)‐pro‐brain natriuretic peptide (BNP) levels and incidence…”
Get full text

Association of SMAD7 genetic markers and haplotypes with colorectal cancer risk by Alidoust, Maryam, Hamzehzadeh, Leila, Khorshid Shamshiri, Asma, Afzaljavan, Fahimeh, Kerachian, Mohammad Amin, Fanipakdel, Azar, Aledavood, Seyed Amir, Allahyari, Abolghasem, Bari, Alireza, Moosanen Mozaffari, Hooman, Goshayeshi, Ladan, Pasdar, Alireza

“…Colorectal cancer (CRC) is one of the common cancers with a high mortality rate worldwide. In Iran, there has been a trend of increased incidence of colorectal…”
Get full text

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial by Allahyari, Abolghasem, Ehsanpour, Ali, Najafi, Behrouz, Ansarinejad, Nafiseh, Mehrzad, Valiollah, Kalantari, Behjat, Raafat, Jahangir, Ghadiany, Mojtaba, Shahi, Farhad, Gharib, Behrooz, Moazed, Vahid, Khosravi, Adnan, Mirpour, Mir Hossein, Salari, Sina, Mortazavizadeh, Seyedmohammadreza, Nekoyi, Amirabbas, Khani, Mohsen, Sadeghi, Alireza, Gharib, Sirus, Bary, Alireza, Mirzania, Mehrzad, Haghighat, Shirin, Razavi, Seyed Mohsen, Emami, Seyed Amir Hossein, Hosseinzadeh, Mehran, Mirbolouk, Mahdi, Sadighi, Sanambar, Shahrasbi, Abdolali, Esfahani, Ali, Gity, Masoumeh, Anjidani, Nassim, Kafi, Hamidreza, Najafi, Safa

“…Breast cancer is the most frequently diagnosed cancer and the leading reason for cancer-related death among women. Neoadjuvant treatment with dual-HER2 (human…”
Get full text

Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial by Allahyari, Abolghasem, Ehsanpour, Ali, Najafi, Behrouz, Ansarinejad, Nafseh, Mehrzad, Valiollah, Kalantari, Behjat, Raafat, Jahangir, Ghadiany, Mojtaba, Shahi, Farhad, Gharib, Behrooz, Moazed, Vahid, Khosravi, Adnan, Mirpour, Mir Hossein, Salari, Sina, Mortazavizadeh, Seyedmohammadreza, Nekoyi, Amirabbas, Khani, Mohsen, Sadeghi, Alireza, Gharib, Sirus, Bary, Alireza, Mirzania, Mehrzad, Haghighat, Shirin, Razavi, Seyed Mohsen, Emami, Seyed Amir Hossein, Hosseinzadeh, Mehran, Mirbolouk, Mahdi, Sadighi, Sanambar, Shahrasbi, Abdolali, Esfahani, Ali, Gity, Masoumeh, Anjidani, Nassim, Kaf, Hamidreza, Najaf, Safa

Get full text

Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study by Riasi, Fatemeh, Ataei Azimi, Sajjad, Allahyari, Abolghasem, Moeini Nodeh, Mohammad, Shakeri, Mohammad T., Kamandi, Mostafa

“…Background and Aims The effect of stopping or reducing the dose of vincristine in diffuse large B‐cell lymphoma (DLBCL) on the outcome and prognosis of the…”
Get full text

Investigating the association between rs6983267 polymorphism and susceptibility to gastrointestinal cancers in Iranian population by Karimi, Farzaneh, Amiri-Moghaddam, Seyedeh Mina, Bagheri, Zakieh, Bahrami, Ahmad Reza, Goshayeshi, Ladan, Allahyari, Abolghasem, Mirsadraee, Marjane, Fanipakdel, Azar, Bari, Alireza, Emadi-Torghabeh, Ali, Kerachian, Mohammad Amin, Rahimi, Hossein, Matin, Maryam M.

“…Genome-wide association studies have revealed that some single nucleotide polymorphisms at 8q24, such as rs6983267, might be effective in susceptibility to…”
Get full text

Supplemental Preparations in Taxane-Induced Neuropathy Management by Sanei, AmirHosein, Abedi, Farshad, Moeini Nodeh, Mohammad, Mohammadpour, Amir Hooshang, Allahyari, Abolghasem, Zemorshidi, Fariba, Arasteh, Omid

“…Taxane-induced peripheral neuropathy (TIPN) is a dose-limiting adverse effect of chemotherapy without any specific treatment. The aim of this paper is to…”
Get full text

A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients by Nodehi, Reza Safaei, Kalantari, Behjat, Raafat, Jahangir, Ansarinejad, Nafiseh, Moazed, Vahid, Mortazavizadeh, Seyed Mohammad Reza, Hosseinzadeh, Mehran, Ghaderi, Bayazid, Jenabian, Arash, Qadyani, Mojtaba, Haghighat, Shirin, Allahyari, Abolghasem, Mirzania, Mehrzad, Seghatoleslami, Mohammad, Payandeh, Mehrdad, Alikhasi, Afsaneh, Kafi, Hamidreza, Shahi, Farhad

“…Abstract Background This study compared efficacy and safety of TA4415V, a trastuzumab biosimilar, with reference trastuzumab in patients with human epidermal…”
Get full text

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial by Allahyari, Abolghasem, Rahimi, Hossein, Khadem-Rezaiyan, Majid, Mozaheb, Zahra, Seddigh-Shamsi, Mohsen, Bary, Alireza, Kamandi, Mostafa, Azimi, Sajad Ataei, HasanAbadi, Saeed Eslami, Noferesti, Alireza, Shariatmaghani, Somayeh Sadat, Rafatpanah, Houshang, Khatami, Shohreh, Imani, Afshin Jabbar, Mortazi, Hassan, Nodeh, Mohammad Moeini

“…In this study, we investigate the effect of hydroxychloroquine on the prevention of Novel Coronavirus Disease (COVID-19) in cancer patients being treated. This…”
Get full text

Clinical characteristics of 200 COVID-19 patients in Mashhad, Iran, February and March 2020 by AkbariRad, Mina, Allahyari, Abolghasem, Ravanshad, Sahar, Mahali, Shima, Ebrahimzadeh, Farnoosh, Mozdourian, Mahnaz, Javidarabshahi, Zahra, Seddigh-Shamsi, Mohsen, Emadzade, Maryam, Ghalibaf, AmirAli

“…Introduction: Coronavirus disease 2019 (COVID-19) is a pulmonary involvement which was reported for the first time in December 2019 in the city of Wuhan, Hubei…”
Get full text

Prognostic Factors and Survival in Acute Myeloid Leukemia Cases: a Report from the Northeast of Iran by Allahyari, Abolghasem, Tajeri, Tarane, Sadeghi, Masoud

“…Background: Acute myeloid leukemia (AML) is a clonal hematopoietic disorder resulting from genetic alterations in normal hematopoietic stem cells. The aim of…”
Get full text

Interaction of perforin and granzyme B and HTLV-1 viral factors is associated with ATL development by Akbarin, Mohammad Mehdi, Farhadi, Sadegh, Allahyari, Abolghasem, Koshayar, Mohammad Mehdi, Shirdel, Abbas, Rahimi, Hossain, Rezaee, Abdolrahim, Mahdifar, Maryam, Mozaheb, Zahra, Mohamadi, Asadollah, Bari, Alireza, Seyedeh Tahereh Mohaddes, Rafatpanah, Houshang

“…Objective(s): Human T cell leukaemia virus type 1 (HTLV-1) is associated with adult T cell leukaemia (ATL), a malignant lymphoproliferative disease that…”
Get full text

A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial by Toogeh, Gholamreza, Faranoush, Mohammad, Razavi, Seyed Mohsen, Jalaeikhoo, Hassan, Allahyari, Abolghasem, Ravanbod, Mohammad Reza, Zarrabi, Fariba, Fallahazad, Vahid, Rezaei Darzi, Ehsan, Alizadeh Fard, Shadi Sadat

“…Chronic lymphocytic leukemia (CLL) is characterized by accumulation of B cells in blood, lymphoid tissues and bone marrow. Addition of rituximab to CLL…”
Get full text

Frequency of FLT3 (ITD, D835) Gene Mutations in Acute Myelogenous Leukemia: a Report from Northeastern Iran by Allahyari, Abolghasem, Sadeghi, Masoud, Ayatollahi, Hossein, Yazdi, Hamed Najjaran, Tavakol, Mohammad

“…Background: FLT3 is mutated in about 1/3 of acute myelogenous leukemia (AML) patients. The aim of the present study was to report the prevalence of FLT3…”
Get full text

Prognostic Role of Red Cell Distribution Width (RDW) in Patients with Diffuse Large B-cell Lymphoma by Kamandi, Neda, Soleimanian, Amirmohammad, Allahyari, Abolghasem, Kamandi, Mostafa

Get full text